Instructions to Authors
INTRACAVERNOSAL INJECTIONS AND FIBROSIS
BEYOND GOVERNMENT TARGETS
Molecular and histological markers in urothelial carcinomas of the upper urinary tract
Genetic polymorphism and pathogenesis of benign prostatic hyperplasia
Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer
The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone
Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy
Is there a relationship between prostate volume and Gleason score?
Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma
Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer
The role of lymph-node dissection in the treatment of upper urinary tract cancer
A safe and simple solution for intravesical tension-free vaginal tape erosion
Is there an alternative to pad tests? Correlation of subjective variables of severity of urinary loss to the 1-h pad test in women with stress urinary incontinence
Erectile haemodynamic status after radical prostatectomy correlates with erectile functional outcome
Laser robotically assisted nerve-sparing radical prostatectomy
Positive surgical margins during robotic radical prostatectomy
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer
The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer
Mitochondrial DNA in serum of patients with prostate cancer
DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder
Prostaglandin revival?
NO ASSOCIATION OF NAD(P)H QUINONE OXIDOREDUCTASE 1 EXPRESSION WITH p53 EXPRESSION OR TUMOUR OUTCOME IN PATIENTS WITH SUPERFICIAL AND MINIMALLY INVASIVE UROTHELIAL BLADDER CANCERS
THE ROLE OF LYMPH-NODE DISSECTION IN THE TREATMENT OF UPPER URINARY TRACT CANCER
Atlas of Laparoscopic Urologic Surgery
The artificial genitourinary sphincter
Abbreviations
Diary
Levels of Evidence